Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Karn

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Journal of Cancer Research and Clinical Oncology|January 30, 2013
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancerDina Schütze, Karin Milde-Langosch, Isabell Witzel, et al.
In Vivo (Athens, Greece)|August 29, 2018
Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer PatientsAhmed El-Balat, Iryna Schmeil, Thomas Karn, et al.
Breast Cancer Research and Treatment|February 6, 2015
Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancersSabrina S Khan, Thomas Karn, W Fraser Symmans, et al.
Breast (Edinburgh, Scotland)|October 29, 2010
SATB1 gene expression and breast cancer prognosisLars C Hanker, Thomas Karn, Loreta Mavrova-Risteska, et al.
Molecular Oncology|August 19, 2014
Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancerNicole Sänger, Eugen Ruckhäberle, Balazs Györffy, et al.
Journal of Cancer Research and Clinical Oncology|February 9, 2013
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancersIsabell Witzel, Monika Graeser, Thomas Karn, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2024
Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric studyIna Shehaj, Slavomir Krajnak, Morva Tahmasbi Rad, et al.
JAMA Oncology|July 28, 2017
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast CancerThomas Karn, Tingting Jiang, Christos Hatzis, et al.
Gynecologic and Obstetric Investigation|March 12, 2024
The Clinical Relevance of Fractional Curettage in the Diagnostic Management of Primary Endometrial CancerMaria Laura Dokara-Friedrich, Marius Loeffler, Ina Shehaj, et al.
Journal of Clinical Pathology|September 2, 2018
Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovaryAhmed El-Balat, Iryna Schmeil, Khayal Gasimli, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Journal of Cancer Research and Clinical Oncology|January 30, 2013
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancerDina Schütze, Karin Milde-Langosch, Isabell Witzel, et al.
In Vivo (Athens, Greece)|August 29, 2018
Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer PatientsAhmed El-Balat, Iryna Schmeil, Thomas Karn, et al.
Breast Cancer Research and Treatment|February 6, 2015
Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancersSabrina S Khan, Thomas Karn, W Fraser Symmans, et al.
Breast (Edinburgh, Scotland)|October 29, 2010
SATB1 gene expression and breast cancer prognosisLars C Hanker, Thomas Karn, Loreta Mavrova-Risteska, et al.
Molecular Oncology|August 19, 2014
Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancerNicole Sänger, Eugen Ruckhäberle, Balazs Györffy, et al.
Journal of Cancer Research and Clinical Oncology|February 9, 2013
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancersIsabell Witzel, Monika Graeser, Thomas Karn, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2024
Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric studyIna Shehaj, Slavomir Krajnak, Morva Tahmasbi Rad, et al.
JAMA Oncology|July 28, 2017
Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast CancerThomas Karn, Tingting Jiang, Christos Hatzis, et al.
Gynecologic and Obstetric Investigation|March 12, 2024
The Clinical Relevance of Fractional Curettage in the Diagnostic Management of Primary Endometrial CancerMaria Laura Dokara-Friedrich, Marius Loeffler, Ina Shehaj, et al.
Journal of Clinical Pathology|September 2, 2018
Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovaryAhmed El-Balat, Iryna Schmeil, Khayal Gasimli, et al.
Pageof 11